Joseph P. Lucia & Associates, LLC Gilead Sciences, Inc. Transaction History

Joseph P. Lucia & Associates, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$57.92 - $72.58 $24,616 - $30,846	425 New	425 $25,000
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $32,439 - $36,820	-500 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$56.65 - $64.55 $28,325 - $32,275	500 New	500 $29,000
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $45,767 - $57,544	-737 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $14,468 - $16,800	200 Added 37.24%	737 $57,000
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $5,323 - $6,818	85 Added 18.81%	537 $40,000
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $1.23 Million - $1.38 Million	-19,896 Reduced 97.78%	452 $31,000
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $1.27 Million - $1.43 Million	20,348 New	20,348 $302,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.